Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Richmond Supports Groundbreaking Study in Alpha-1 Antitrypsin Deficiency (AATD) with Beam Therapeutics

3
December 2025

Richmond congratulates Beam Therapeutics on the preliminary results from the first three dose levels of its ongoing Phase 1/2 study...

View Articles

Richmond wins a Breakthrough Culture Award for committing to a people-first culture

13
March 2025

Richmond has been recognised as a great place to work and as one of the Breakthrough Culture Award winners for 2024.

View Articles

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

17
February 2025

We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...

View Articles

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

10
February 2025

The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...

View Articles

Richmond trains taxi drivers to deliver lifesaving CPR

3
December 2024

Richmond has just trained a first group of taxi drivers to deliver cardiopulmonary resuscitation (CPR) aimed at saving the lives of their passengers.

View Articles

Richmond Pharmacology Announces Promotions of Dr Matej Goricar and Dr Amir Majid

1
December 2024

Richmond is pleased to announce the promotions of Dr Matej Goricar and Dr Amir Majid to senior roles within the Medical Directorate as Associate Medical Directors.

View Articles

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event